Suppr超能文献

治疗前的非刚性变化分析可以辅助对头颈部患者进行稳健的强度调制质子治疗计划选择。

Pre-treatment analysis of non-rigid variations can assist robust intensity-modulated proton therapy plan selection for head and neck patients.

机构信息

Department of Medical Physics and Biomedical Engineering, University College London, Gower Street, London, UK.

Saudi Proton Therapy Center, King Fahad Medical City, Riyadh, Saudi Arabia.

出版信息

Med Phys. 2022 Dec;49(12):7683-7693. doi: 10.1002/mp.15971. Epub 2022 Oct 6.

Abstract

PURPOSE

To incorporate small non-rigid variations of head and neck patients into the robust evaluation of intensity-modulated proton therapy (IMPT) for the selection of robust treatment plans.

METHODS

A cohort of 20 nasopharynx cancer patients with weekly kilovoltage CT (kVCT) and 15 oropharynx cancer patients with weekly cone-beam CT (CBCT) were retrospectively included. Anatomical variations between week 0/week 1 of treatment were acquired using deformable image registration (DIR) for all 35 patients and then applied to the planning CT of four patients who have kVCT scanned each week to simulate potential small non-rigid variations (sNRVs). The robust evaluations were conducted on IMPT plans with: (1) different number of beam fields from 3-field to 5-field; (2) different beam angles. The robust evaluation before treatment, including the sNRVs and setup uncertainty, referred to as sNRV+R evaluation was compared with the conventional evaluation (without sNRVs) in terms of robustness consistency with the gold standard evaluation based on weekly CT.

RESULTS

Among four patients (490 scenarios), we observed a maximum difference in the sNRV+R evaluation to the nominal dose of: 9.37% dose degradation on D of clinical target volumes (CTVs), increase in mean dose (D ) of parotid 11.87 Gy, increase in max dose (D ) of brainstem 20.82 Gy. In contrast, in conventional evaluation, we observed a maximum difference to the nominal dose of: 7.58% dose degradation on D of the CTVs, increase in parotid D by 4.88 Gy, increase in brainstem D by 13.5 Gy. In the measurement of the robustness ranking consistency with the gold standard evaluation, the sNRV+R evaluation was better or equal to the conventional evaluation in 77% of cases, particularly, better on spinal cord, parotid glands, and low-risk CTV.

CONCLUSION

This study demonstrated the additional dose discrepancy that sNRVs can make. The inclusion of sNRVs can be beneficial to robust evaluation, providing information on clinical uncertainties additional to the conventional rigid isocenter shift.

摘要

目的

将头颈部患者的小非刚性变化纳入强适形调强质子治疗(IMPT)的稳健性评估中,以选择稳健的治疗计划。

方法

回顾性纳入 20 例鼻咽癌患者和 15 例口咽癌患者,每周进行千伏级 CT(kVCT)和锥形束 CT(CBCT)检查。对所有 35 例患者的治疗第 0 周/第 1 周的图像进行形变图像配准(DIR),获取解剖学变化,并将其应用于每周进行 kVCT 扫描的 4 例患者的计划 CT 中,以模拟潜在的小非刚性变化(sNRVs)。对 IMPT 计划进行稳健性评估,包括:(1)从 3 野到 5 野的不同射束数;(2)不同的射束角度。治疗前的稳健性评估包括 sNRVs 和设置不确定性,称为 sNRV+R 评估,与基于每周 CT 的金标准评估的稳健性一致性进行比较。

结果

在 4 例患者(490 种情况)中,我们观察到 sNRV+R 评估与名义剂量的最大差异为:CTVs 的 D 剂量下降 9.37%,腮腺 1 的平均剂量(D )增加 11.87 Gy,脑干 1 的最大剂量(D )增加 20.82 Gy。相比之下,在常规评估中,我们观察到与名义剂量的最大差异为:CTVs 的 D 剂量下降 7.58%,腮腺 D 增加 4.88 Gy,脑干 D 增加 13.5 Gy。在与金标准评估的稳健性排名一致性的测量中,sNRV+R 评估在 77%的情况下优于或等同于常规评估,特别是在脊髓、腮腺和低危 CTV 方面。

结论

本研究表明,sNRVs 可能会导致额外的剂量差异。纳入 sNRVs 可以有助于稳健性评估,提供常规刚性等中心位移之外的临床不确定性信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f4/10092578/a51ac094aca1/MP-49-7683-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验